Biomet Inc (BMET-Q) Stock Predictions - Stockchase
WATCH LIST
8
Biomet Inc (BMET-Q)

ON STOCKCHASE SINCE Oct 2001

orthopedic specialties

biotechnology/pharmaceutical

Biomet Inc

BMET-Q

0 watching          
Join the Discussion

Biomet Inc (BMET-Q) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about BMET-Q



  • All
  • Filtered
Signal Opinion Expert
TOP PICK
Biomet Inc(BMET-Q) 

June 2, 2005

Has $2 billion in sales. Knee and hip business. Likes this business. Great demographics with an older population. Wonderful cash flow earnings growth. Limited competition so reasonably stable.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has $2 billion in sales. Knee and hip business. Likes this business. Great demographics with an older population. Wonderful cash flow earnings growth. Limited competition so reasonably stable.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Danny Tomka

Portfolio , MFC Global Investmen...

Price Price
$38.220
Owned Owned
Yes

TOP PICK
Biomet Inc(BMET-Q) 

March 29, 2005

Primary business is the hip/knee replacements. What has generated a product cycle recently is that they can do hips less invasively with only small incisions and knees can be replaced. Stock has been coming off recently. Trades around 19 X earnings. Top line growth is 15% and earnings closer to 20%.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Primary business is the hip/knee replacements. What has generated a product cycle recently is that they can do hips less invasively with only small incisions and knees can be replaced. Stock has been coming off recently. Trades around 19 X earnings. Top line growth is 15% and earnings closer to 20%.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Danny Tomka

Portfolio , MFC Global Investmen...

Price Price
$38.760
Owned Owned
Yes

TOP PICK
Biomet Inc(BMET-Q) 

November 12, 2004

Generally cautious on the mainstream pharmaceutical companies, but this company is well positioned to benefit from the aging baby boomers with artificial hips and knees.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Generally cautious on the mainstream pharmaceutical companies, but this company is well positioned to benefit from the aging baby boomers with artificial hips and knees.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Christine Calli

Chief Mark, Bessemer Trust...

Price Price
$48.530
Owned Owned
No

TOP PICK
Biomet Inc(BMET-Q) 

September 17, 2004

Health care looks very attractive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Health care looks very attractive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Richard Bernsti

Chief U.S., Merrill Lynch...

Price Price
$47.470
Owned Owned
No

PAST TOP PICK
Biomet Inc(BMET-Q) 

July 17, 2003

(Was a top pick on May 23/03. No change.) An age demographic play.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Was a top pick on May 23/03. No change.) An age demographic play.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brad Willock

Vice Presi, RBC Asset Management...

Price Price
$28.490
Owned Owned
Unknown

TOP PICK
Biomet Inc(BMET-Q) 

May 23, 2003

A little volatile. No debt. Earnings growth is 15/20% a year. Has a lot of sales in Europe which acts as a hedge on currency. Age demographics means more demand for their products.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A little volatile. No debt. Earnings growth is 15/20% a year. Has a lot of sales in Europe which acts as a hedge on currency. Age demographics means more demand for their products.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brad Willock

Vice Presi, RBC Asset Management...

Price Price
$28.430
Owned Owned
Unknown

PAST TOP PICK
Biomet Inc(BMET-Q) 

April 22, 2003

(Was a top pick on Feb 13. Up 8%.) Still likes. Would continue to buy under $30.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Was a top pick on Feb 13. Up 8%.) Still likes. Would continue to buy under $30.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brad Willock

Vice Presi, RBC Asset Management...

Price Price
$30.610
Owned Owned
Unknown

TOP PICK
Biomet Inc(BMET-Q) 

October 16, 2001

Medical devices have been holding up well and Biomet is the world leader in orthopedic devices. Growing revenues. Some competition.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Medical devices have been holding up well and Biomet is the world leader in orthopedic devices. Growing revenues. Some competition.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Burrows

President , Barometer Capital Ma...

Price Price
$32.130
Owned Owned
Unknown

Showing 1 to 8 of 8 entries
Successfully Saved Company
Successfully Saved Company